http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872070-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcc35f152994b9dd00422a05c7e7572f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
filingDate 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed7b2f60646f61b214ffebb865618a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6298f3c1c727b5eb69931702f64a99bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd9757c3ce1247c0bc12193da23a4adb
publicationDate 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102872070-B
titleOfInvention Application of Houttuynoid C to preparing drugs for treating prostate cancer
abstract The invention discloses application of Houttuynoid C to preparing drugs for treating prostate cancer, belonging to the technical field of new uses of the drugs. According to the invention, found by in vitro methyl thiazolyl tetrazolium (MTT) antineoplastic activity evaluation, Houttuynoid C also has remarkable inhibition effect on the growth of human prostate cancer cell lines ALVA, gpc-1, 9L-B and Du 145. Therefore, Houttuynoid C can be used for preparing the drugs for resisting the prostate cancer and has good development and application prospects. The application of Houttuynoid C to preparing the drugs for treating the prostate cancer, disclosed by the invention, is firstly published; the framework type is brand new; and the activity of inhibiting the prostate cancer cells is unexpectedly strong.
priorityDate 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID16752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412228694
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID16752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148919969

Total number of triples: 19.